Strides Arcolab intends to invest $20 million in Biotech business

26 Sep 2014 Evaluate

Strides Arcolab intends to invest $20 million in Biotech business from the amount to be received from Mylan. The company has agreed to receive an amount of $150 million from Mylan Inc., USA as the full and final settlement against the Contingent Holdback of up to $250 million. After investments and providing for taxes the balance will be available for distribution to shareholders subject to the approval of board of directors.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

901.05 -3.75 (-0.41%)
23-Mar-2026 11:28 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1763.10
Dr. Reddys Lab 1277.00
Cipla 1239.00
Zydus Lifesciences 877.00
Lupin 2293.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×